Qing You

1.4k total citations
34 papers, 945 citations indexed

About

Qing You is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Qing You has authored 34 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Biomedical Engineering, 18 papers in Molecular Biology and 6 papers in Materials Chemistry. Recurrent topics in Qing You's work include Nanoplatforms for cancer theranostics (17 papers), Extracellular vesicles in disease (10 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). Qing You is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Extracellular vesicles in disease (10 papers) and Photoacoustic and Ultrasonic Imaging (5 papers). Qing You collaborates with scholars based in China, Singapore and United States. Qing You's co-authors include Fengping Tan, Jinping Wang, Yanlian Yang, Ling Zhu, Qi Sun, Jingyi Liu, Nan Li, Xiaoyuan Chen, Huayi Wang and Chen Wang and has published in prestigious journals such as Advanced Materials, Nature Nanotechnology and Biomaterials.

In The Last Decade

Qing You

32 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing You China 16 676 374 257 203 163 34 945
Si‐Yuan Peng China 15 957 1.4× 476 1.3× 291 1.1× 224 1.1× 140 0.9× 22 1.3k
Tuanwei Li China 18 701 1.0× 506 1.4× 184 0.7× 240 1.2× 191 1.2× 37 949
Jingyi Zhu China 10 530 0.8× 294 0.8× 203 0.8× 167 0.8× 189 1.2× 26 756
Weiyun Zhang China 18 822 1.2× 417 1.1× 311 1.2× 328 1.6× 160 1.0× 31 1.1k
Yaqian Du China 15 584 0.9× 403 1.1× 311 1.2× 104 0.5× 141 0.9× 30 903
Yongzhi Men China 12 551 0.8× 192 0.5× 298 1.2× 308 1.5× 188 1.2× 16 950
Chuangli Zhang China 10 1.0k 1.5× 488 1.3× 216 0.8× 220 1.1× 200 1.2× 14 1.2k
Iris Marangon France 13 616 0.9× 359 1.0× 232 0.9× 352 1.7× 80 0.5× 16 968
Yanhong Duo China 16 773 1.1× 419 1.1× 362 1.4× 188 0.9× 196 1.2× 21 1.0k

Countries citing papers authored by Qing You

Since Specialization
Citations

This map shows the geographic impact of Qing You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing You more than expected).

Fields of papers citing papers by Qing You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing You. The network helps show where Qing You may publish in the future.

Co-authorship network of co-authors of Qing You

This figure shows the co-authorship network connecting the top 25 collaborators of Qing You. A scholar is included among the top collaborators of Qing You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing You. Qing You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yuhua, Qing You, Yu Zhang, et al.. (2025). Human induced pluripotent stem cell derived nanovesicles for cardiomyocyte protection and proliferation. Bioactive Materials. 50. 585–602.
2.
You, Qing, Gege Wu, Hui Li, et al.. (2025). A nanovaccine targeting cancer stem cells and bulk cancer cells for postoperative cancer immunotherapy. Nature Nanotechnology. 20(9). 1298–1311. 3 indexed citations
3.
Liu, Jingyi, et al.. (2024). Ultrasound-nanovesicles interplay for theranostics. Advanced Drug Delivery Reviews. 205. 115176–115176. 15 indexed citations
4.
Liu, Jingyi, Qing You, Siyuan Ye, et al.. (2024). T lymphocyte-derived immunogenic hybrid nanovesicles for immunosuppression reversion and boosted photothermal immunotherapy. Nano Today. 55. 102148–102148. 13 indexed citations
5.
You, Qing, Lin Yang, Jiahui Gong, et al.. (2024). Integrating lipidomics, 16S rRNA sequencing, and network pharmacology to explore the mechanism of Qikui granule in treating diabetic kidney disease mice. Journal of Chromatography B. 1250. 124378–124378. 1 indexed citations
7.
Fu, Zhao, Qing You, Wei Xiao, et al.. (2024). Enhanced photodynamic therapy through multienzyme-like MOF for cancer treatment. Frontiers in Bioengineering and Biotechnology. 11. 1338257–1338257. 7 indexed citations
8.
You, Qing, Huayi Wang, Jingyi Liu, et al.. (2024). ICAM‐1‐Expressing Extracellular Vesicles Enable Sequential Delivery Barrier‐Breaking and Microenvironment Modulating for Glioblastoma Stem Cell Inhibition. Advanced Functional Materials. 34(46). 4 indexed citations
10.
Wu, Gege, et al.. (2024). AcousticRobots: Smart acoustically powered micro-/nanoswimmers for precise biomedical applications. Advanced Drug Delivery Reviews. 207. 115201–115201. 21 indexed citations
11.
Feng, Yanlin, Jianlin Wang, Fangfang Cao, et al.. (2023). Mace‐Like Plasmonic Au‐Pd Heterostructures Boost Near‐Infrared Photoimmunotherapy. Advanced Science. 10(6). e2204842–e2204842. 33 indexed citations
12.
You, Qing, Junqi Wang, Zhiya Dong, et al.. (2023). The functional study of a novel MKRN3 missense mutation associated with familial central precocious puberty. American Journal of Medical Genetics Part A. 194(4). e63460–e63460. 2 indexed citations
13.
You, Qing, Xiaopeng Ma, Chen Wang, et al.. (2023). Nanomaterials for visualized tumor surgical navigation and postoperative recurrence inhibition. Nano Research. 3 indexed citations
14.
Ye, Siyuan, Qing You, Huayi Wang, et al.. (2022). Nanostructures and Nanotechnologies for the Detection of Extracellular Vesicle. Advanced Biology. 7(2). e2200201–e2200201. 8 indexed citations
15.
You, Qing, Min Liu, Shuaihu Li, et al.. (2022). Remodeling of dermal adipose tissue alleviates cutaneous toxicity induced by anti-EGFR therapy. eLife. 11. 2 indexed citations
16.
Zhang, Kaiyue, Xiaocui Fang, Qing You, et al.. (2020). Novel peptide-directed liposomes for targeted combination therapy of breast tumors. Materials Advances. 1(9). 3483–3495. 3 indexed citations
17.
Wang, Siyu, Qing You, Jinping Wang, et al.. (2019). MSOT/CT/MR imaging-guided and hypoxia-maneuvered oxygen self-supply radiotherapy based on one-pot MnO2-mSiO2@Au nanoparticles. Nanoscale. 11(13). 6270–6284. 62 indexed citations
18.
Wang, Jinping, Li Liu, Qing You, et al.. (2018). All-in-One Theranostic Nanoplatform Based on Hollow MoSx for Photothermally-maneuvered Oxygen Self-enriched Photodynamic Therapy. Theranostics. 8(4). 955–971. 86 indexed citations
19.
Sheng, Xiangpeng, Qing You, ZeNan Chang, et al.. (2017). Bacterial effector NleL promotes enterohemorrhagic E. coli-induced attaching and effacing lesions by ubiquitylating and inactivating JNK. PLoS Pathogens. 13(7). e1006534–e1006534. 26 indexed citations
20.
Wang, Jinping, Xiaojuan Pang, Xiaoxiao Tan, et al.. (2017). A triple-synergistic strategy for combinational photo/radiotherapy and multi-modality imaging based on hyaluronic acid-hybridized polyaniline-coated WS2 nanodots. Nanoscale. 9(17). 5551–5564. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026